Evox Therapeutics Limited

About the company

Evox Therapeutics Ltd is a biotechnology company focused on developing innovative genetic medicines for serious diseases. Founded in 2016 and headquartered in Oxford, UK, the company is advancing technologies designed to improve the delivery of genetic medicines to difficult-to-reach tissues, including the central nervous system. Evox’s research is centered on exosome-based drug delivery and its proprietary ExoEdit® platform, with programs focused on genetically driven and neurodegenerative diseases. The company brings together expertise across research, drug development, translational medicine, manufacturing, business development, and other functions to advance new therapeutic approaches. As Evox continues to develop its technology and pipeline, it seeks talented, dependable, and detail-oriented professionals who can contribute to its operations and support its broader mission of advancing innovative medicines.